Full Product Name
CTSA Polyclonal Antibody
Product Synonym Names
GLB2; GSL; NGBE; PPCA; PPGB
Product Gene Name
anti-CTSA antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for P10619
Species Reactivity
Human, Mouse
Purity/Purification
Affinity Purification
Immunogen
A synthetic peptide of human CTSA
Storage Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Preparation and Storage
Store at 4 degree C. Avoid freeze/thaw cycles.
Other Notes
Small volumes of anti-CTSA antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-CTSA antibody
This gene encodes a member of the peptidase S10 family of serine carboxypeptidases. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate two chains that comprise the heterodimeric active enzyme. This enzyme possesses deamidase, esterase and carboxypeptidase activities and acts as a scaffold in the lysosomal multienzyme complex. Mutations in this gene are associated with galactosialidosis.
Product Categories/Family for anti-CTSA antibody
Primary antibody
Applications Tested/Suitable for anti-CTSA antibody
Western Blot (WB), Immunohistochemistry (IHC)
Application Notes for anti-CTSA antibody
WB: 1:500 - 1:1000
IHC: 1:20 - 1:50
Western Blot (WB) of anti-CTSA antibody
Western blot analysis of extracts of various cell lines, using CTSA antibody at 1:1000 dilution.
Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (MBS128200) at 1:10000 dilution.
Lysates/proteins: 25ug per lane.
Blocking buffer: 3% nonfat dry milk in TBST.
Detection: ECL Basic Kit.
Exposure time: 1s.

NCBI/Uniprot data below describe general gene information for CTSA. It may not necessarily be applicable to this product.
NCBI Accession #
P10619.2
[Other Products]
UniProt Primary Accession #
P10619
[Other Products]
UniProt Secondary Accession #
Q561W6; Q5JZH1; Q96KJ2; Q9BR08; Q9BW68; B2R798[Other Products]
UniProt Related Accession #
P10619[Other Products]
NCBI Official Full Name
Lysosomal protective protein
NCBI Official Synonym Full Names
cathepsin A
NCBI Official Symbol
CTSA??[Similar Products]
NCBI Official Synonym Symbols
GSL; GLB2; NGBE; PPCA; PPGB
??[Similar Products]
NCBI Protein Information
lysosomal protective protein
UniProt Protein Name
Lysosomal protective protein
UniProt Synonym Protein Names
Carboxypeptidase C; Carboxypeptidase L; Cathepsin A; Protective protein cathepsin A; PPCA
Protein Family
Lysosomal protective protein
UniProt Gene Name
CTSA??[Similar Products]
UniProt Synonym Gene Names
PPGB; PPCA??[Similar Products]
NCBI Summary for CTSA
This gene encodes a member of the peptidase S10 family of serine carboxypeptidases. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate two chains that comprise the heterodimeric active enzyme. This enzyme possesses deamidase, esterase and carboxypeptidase activities and acts as a scaffold in the lysosomal multienzyme complex. Mutations in this gene are associated with galactosialidosis. [provided by RefSeq, Nov 2015]
UniProt Comments for CTSA
CTSA: Protective protein appears to be essential for both the activity of beta-galactosidase and neuraminidase, it associates with these enzymes and exerts a protective function necessary for their stability and activity. This protein is also a carboxypeptidase and can deamidate tachykinins. Defects in CTSA are the cause of galactosialidosis (GSL). A lysosomal storage disease associated with a combined deficiency of beta-galactosidase and neuraminidase, secondary to a defect in cathepsin A. All patients have clinical manifestations typical of a lysosomal disorder, such as coarse facies, cherry red spots, vertebral changes, foam cells in the bone marrow, and vacuolated lymphocytes. Three phenotypic subtypes are recognized. The early infantile form is associated with fetal hydrops, edema, ascites, visceromegaly, skeletal dysplasia, and early death. The late infantile type is characterized by hepatosplenomegaly, growth retardation, cardiac involvement, and a normal or mildly affected mental state. The juvenile/***** form is characterized by myoclonus, ataxia, angiokeratoma, mental retardation, neurologic deterioration, absence of visceromegaly, and long survival. Belongs to the peptidase S10 family.
Protein type: EC 3.4.16.5; Endoplasmic reticulum; Mitochondrial; Protease
Chromosomal Location of Human Ortholog: 20q13.12
Cellular Component: endoplasmic reticulum; extracellular region; intracellular membrane-bound organelle; lysosomal lumen; membrane; nucleoplasm
Molecular Function: carboxypeptidase activity; enzyme activator activity; exo-alpha-sialidase activity; serine carboxypeptidase activity
Biological Process: glycosphingolipid metabolic process; intracellular protein transport; neutrophil degranulation; proteolysis; proteolysis involved in cellular protein catabolic process; regulation of protein stability
Disease: Galactosialidosis
Research Articles on CTSA
1. Galactosialidosis is a rare lysosomal storage disease caused by a combined deficiency of GM1 beta-galactosidase (beta-gal) and neuraminidase secondary to a defect of a lysosomal enzyme protective protein/cathepsin A (PPCA) and mutation in CTSA gene.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.